Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

34.85p
   
  • Change Today:
    -0.60p
  • 52 Week High: 65.00
  • 52 Week Low: 25.50
  • Currency: UK Pounds
  • Shares Issued: 301.45m
  • Volume: 408,913
  • Market Cap: £105.06m
  • RiskGrade: 479

Sector movers: AstraZeneca, Shire lift pharma stocks on upbeat guidance

Date: Tuesday 14 Jan 2014

LONDON (ShareCast) - Decent gains from AstraZeneca and Shire gave the pharmaceuticals sector a boost on Tuesday as both firms gave confident outlooks.

At the JP Morgan Healthcare Conference in San Francisco, AstraZeneca Chief Executive Pascal Soriot said he expects the company to return to growth sooner than analysts currently predict.

He said that new incoming drugs from the company’s portfolio as well as the buy-out of Bristol-Myers Squibb from their diabetes alliance should help halt a decline in sales. Sales have been under pressure over the last year due to a number of patent expiries and competition from generic versions of its drugs.

“AstraZeneca now expects 2017 revenues to be broadly in line with 2013 revenues,” he said.

The share price was 2.5% higher at around 3,755p by 15:50 on Tuesday.

Toby Morris, Senior Sales Trader at CMC Markets, said: “The update comes ahead of a 2013 number release on Feb 6th, with a strong pipeline versus 12 months ago providing a boost in optimism and sending the stock higher.”

Shire, meanwhile, raised its earnings guidance for 2013 to the upper end of previous expectations, pushing the stock up 2.4% to 2,981p.

Shire shares spiked immediately higher this afternoon as the Dublin-headquartered company put out a short statement from Chief Executive Flemming Ornskov that confirmed a strong finish to the year.

Ornskov, who had been addressing investors at the same conference in San Francisco as AstraZeneca’s Soriot, also added that he remained confident the company would deliver earnings for 2014 in line with the November 2013 consensus forecast (excluding ViroPharma).

Others in the sector including Summit Corporation, Futura Medical and Skyepharma were making decent gains today.

Vectura was also higher after the respiratory development company confirmed that its partner Sandoz has received Swedish marketing approval for their inhaler product AirFluSal Forspiro.




Top performing sectors so far today
Technology Hardware & Equipment 1,176.48 +1.16%
Pharmaceuticals & Biotechnology 11,859.30 +0.85%
Industrial Transportation 3,342.59 +0.78%
Media 6,494.69 +0.73%
Household Goods & Home Construction 11,269.09 +0.71%

Bottom performing sectors so far today
Electronic & Electrical Equipment 4,505.01 -1.25%
Industrial Metals & Mining 1,291.41 -1.24%
Financial Services 7,863.20 -1.08%
Oil & Gas Producers 8,257.45 -1.01%
Forestry & Paper 10,922.16 -0.98%

BC

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 34.85p
Change Today -0.60p
% Change -1.69 %
52 Week High 65.00
52 Week Low 25.50
Volume 408,913
Shares Issued 301.45m
Market Cap £105.06m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.72% below the market average47.72% below the market average47.72% below the market average47.72% below the market average47.72% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average
Price Trend
14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average
60.71% above the sector average60.71% above the sector average60.71% above the sector average60.71% above the sector average60.71% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
16:35 9,297 @ 34.85p
16:35 3,064 @ 34.85p
16:35 1,233 @ 34.85p
16:35 703 @ 34.85p
16:35 2,913 @ 34.85p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page